The stock slumped 7.4 per cent on Wednesday to end at Rs 520.35—a five-month-low.

The scrip was trading 4.31 per cent down at Rs 537.50 at around 10.00 am (IST).

Sun Pharma posted a total income of Rs 6846 crore, a 4 per cent growth.

Analysts in an ET NOW poll had estimated a profit of Rs 975 crore.

Sun Pharma has reported a consolidated net profit of Rs 982.51 crore for the June quarter.

The drug in question is CEQUA (cyclosporine ophthalmic solution) 0.09 per cent.

In the works for the last three to four years, these pills were used extensively in the highvoltage 'Livewire' exercise conducted by IAF.

The company had reported consolidated profit of Rs 1,471.82 crore in the corresponding quarter of last year.

The group has also received the tentative approval for Solifenacin Succinate tablets in strengths of 5 mg and 10 mg, Zydus Cadila said.

Some analysts suggested that investors willing to overlook the subdued outlook.

It eventually closed the day 4.70 per cent higher at Rs 472.50.

The pharma major had reported a profit of Rs 2,033.71 crore in the same quarter last year.

"Sun Pharmaceutical Industries Ltd, and one of its wholly-owned subsidiaries have entered into settlements with certain plaintiffs in re Mo...

A lot of researchers are thinking about how to genetically engineer crops and food animals to help them withstand post-climate change heat.

Oxford and Harvard scientists claim that 'smart drug' modafinil can enhance decision-making and planning skills.

Entrepreneur Dave Asprey says smart medication has enabled him to hack his own body to work more efficiently.

"The company has received approval from the US Food & Drug Administration (USFDA) to manufacture and market Modafinil tablets USP 100mg and...